COVID-19 Clinical Trial
Official title:
Prospective Descriptive Study on the Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid19
Clinical thoracic ultrasound plays an important role in the exploration, diagnosis and
follow-up of thoracic pathologies.
The COVID (Coronavirus Disease) epidemic is leading to a large influx of patients in the
emergency department with respiratory disorders. The rapid diagnosis of respiratory disorders
in infected patients is important for further management.
Chest ultrasound has already demonstrated its value in the diagnosis of pneumonia in the
emergency department with superiority over chest X-ray.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in
general and of COVID in particular.
Chest ultrasound has already shown its value in the diagnosis of pneumonia in the emergency
department with superiority over chest X-ray.
However, there is little data on the thoracic ultrasound semiology of viral pneumonia in
general and of COVID in particular.
Peng reported data from 20 patients and compared them to chest CT. The abnormalities are a
thickening of the pleuropneumonia line, an interstitial syndrome with B lines, corresponding
to frosted glass opacities, confluent B lines (snowstorm appearance) corresponding to
interstitial infiltrate, sub-pleural alveolar opacities corresponding to sub-pleural
condensations, more frank alveolar images corresponding to alveolar opacities. A multifocal
aspect was associated with involvement of more than 2 lobes. However, the frequency of these
abnormalities as well as the sensitivity of the echo are not detailed in this article.
Another Italian article describes a clinical case of COVID-19 pneumonia with sub-pleural
involvement and irregularity of the pleuro-pulmonary line.
Clinical thoracic ultrasound has a major potential interest during the COVID epidemic:
available at the patient's bedside, avoiding the need to move around, feasible for the
physician during his visit, easy to clean especially if ultraportable devices are used, fast
and not exposing the staff any more than the usual clinical examination.
In order to determine whether this technique is useful in the management of infected patients
or patients suspected of COVID-19 infection with respiratory signs, we propose a descriptive
prospective study evaluating the ultrasound semiology of COVID-19 pneumonia and the interest
of ultrasound in the evolutionary follow-up of these patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|